{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:13:05Z","timestamp":1785420785569,"version":"3.56.0"},"reference-count":47,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Al-Ahlyyia ammanu university","award":["Faculty of Graduate studies"],"award-info":[{"award-number":["Faculty of Graduate studies"]}]},{"award":["Faculty of Graduate studies"],"award-info":[{"award-number":["Faculty of Graduate studies"]}],"id":[{"id":"https:\/\/ror.org\/00xddhq60","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The AKT2 gene, located on chromosome 19, encodes a protein involved in key cellular processes like metabolism, proliferation, and survival. Abnormalities in the PI3K\/AKT pathway, including AKT2, contribute to tumor progression. AKT2 promotes cell survival, growth, and resistance to therapy. Overexpression or hyperactivation of AKT2 is linked to prostate cancer (PC) development, making it a potential therapeutic target. This study aimed to investigate the frequency and distribution of AKT2 variants in a cohort of Jordanian men diagnosed with PC and to evaluate the relationship between these genetic variations and clinicopathological parameters, including age, tumor stage, PSA levels, and Gleason score. Formalin-fixed paraffin-embedded (FFPE) tissue samples (n = 123) were collected from Jordanian patients diagnosed with prostate adenocarcinoma. The collected samples underwent DNA extraction, followed by PCR amplification. Subsequently, exon 3 of AKT2 was sequenced. The prevalence of AKT2 mutations was 5.7% in the population studied. Six mutations were identified: two missense mutations (Pro51Ser and Gly33Ser), two synonymous, one splice acceptor, and one intron variant. The variants were not significantly correlated with clinical parameters; however, the prevalence of the AKT2 mutations suggests potential relevance to PC pathogenesis. The prevalence of AKT2 mutations in the current cohort suggested a potential role of AKT2 in PC pathogenesis in the Jordanian population. Further genetic studies covering the whole AKT2 gene and the downstream pathway are required for a better understanding of PC genetics.<\/jats:p>","DOI":"10.3390\/ijms27104228","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:49:09Z","timestamp":1778572149000},"page":"4228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort"],"prefix":"10.3390","volume":"27","author":[{"given":"Nuseibah","family":"Rahahlah","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, P.O. Box 115, Amman 19111, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3108-6022","authenticated-orcid":false,"given":"Zina","family":"Al-Alami","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, P.O. Box 115, Amman 19111, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-7184","authenticated-orcid":false,"given":"Mohammed S.","family":"Alorjani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9939-9522","authenticated-orcid":false,"given":"Asmaa","family":"Al-Smadi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1954-0678","authenticated-orcid":false,"given":"Sewar","family":"Obeidat","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Otoom","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-429X","authenticated-orcid":false,"given":"Raed M.","family":"Al-Zoubi","sequence":"additional","affiliation":[{"name":"Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar"},{"name":"Department of Biomedical Sciences, QU-Health, College of Health Sciences, Qatar University, Doha 2713, Qatar"},{"name":"Department of Chemistry, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Al Bashir","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-4777","authenticated-orcid":false,"given":"Mazhar Salim","family":"Al Zoubi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.euo.2025.04.008","article-title":"Years of life lost in metastatic and locally advanced prostate cancer","volume":"8","author":"Falkenbach","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ofner, H., Kramer, G., Shariat, S.F., and Hassler, M.R. (2025). TP53 deficiency in the natural history of prostate cancer. Cancers, 17.","DOI":"10.3390\/cancers17040645"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2016.09.026","article-title":"Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence","volume":"69","author":"Markozannes","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10689-021-00227-3","article-title":"Genetic predisposition to prostate cancer: An update","volume":"21","author":"Eeles","year":"2022","journal-title":"Fam. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/curroncol30020178","article-title":"Underlying features of prostate cancer\u2014Statistics, risk factors, and emerging methods for its diagnosis","volume":"30","author":"Berenguer","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41585-022-00622-0","article-title":"Race and prostate cancer: Genomic landscape","volume":"19","author":"Owiredu","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/pros.24353","article-title":"The evolving landscape of prostate cancer somatic mutations","volume":"82","author":"Cotter","year":"2022","journal-title":"Prostate"},{"key":"ref_10","first-page":"1579","article-title":"TP53 gene mutations in prostate cancer progression. Anticancer research","volume":"30","author":"Ecke","year":"2010","journal-title":"Anticancer. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.31557\/APJCP.2020.21.11.3365","article-title":"TP53, SPOP and PIK3CA genes status in prostate cancer","volume":"21","author":"Otoum","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bjc.6602007","article-title":"ATM polymorphisms as risk factors for prostate cancer development","volume":"91","author":"Angele","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/bjc.2012.146","article-title":"Germline BRCA1 mutations increase prostate cancer risk","volume":"106","author":"Leongamornlert","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15537\/smj.2020.1.24759","article-title":"BRCA2 gene mutation and prostate cancer risk: Comprehensive review and update","volume":"41","author":"Junejo","year":"2020","journal-title":"Saudi Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.3390\/cimb46090586","article-title":"Novel mutations in AKT1 gene in prostate cancer patients in Jordan","volume":"46","author":"Alasmar","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/humu.20271","article-title":"Germline mutations of the MSR1 gene in prostate cancer families from Germany","volume":"27","author":"Maier","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1086\/340450","article-title":"Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer","volume":"70","author":"Ikonen","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bju.12269","article-title":"Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection","volume":"113","author":"Javed","year":"2014","journal-title":"BJU Int."},{"key":"ref_19","first-page":"6038","article-title":"ELAC2\/HPC2 involvement in hereditary and sporadic prostate cancer","volume":"61","author":"Ikonen","year":"2001","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S.J.M. (2022). Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_21","first-page":"24","article-title":"Polymorphisms of 5\u2019-UTR of rad51 gene in prostate cancer","volume":"16","author":"Salim","year":"2018","journal-title":"\u042d\u043ao\u043bo\u0433\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0435\u043d\u0435\u0442\u0438\u043a\u0430"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1541-7786.MCR-20-1066","article-title":"Emerging roles for AKT isoform preference in cancer progression pathways","volume":"19","author":"Degan","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_23","first-page":"4241","article-title":"Recurrent AKT mutations in human cancers: Functional consequences and effects on drug sensitivity","volume":"7","author":"Kyung","year":"2015","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a therapeutic target for cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E1031","DOI":"10.1152\/ajpendo.00204.2006","article-title":"Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle","volume":"291","author":"Sakamoto","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_26","first-page":"e210285","article-title":"Finnish-specific AKT2 gene variant leads to impaired insulin signalling in myotubes","volume":"70","author":"Datta","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Maekawa, S., Takata, R., and Obara, W. (2024). Molecular mechanisms of prostate cancer development in the precision medicine era: A comprehensive review. Cancers, 16.","DOI":"10.3390\/cancers16030523"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ncrna.2024.03.005","article-title":"miR-4716\u20133p and the target AKT2 Gene\/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population","volume":"9","author":"Nandwa","year":"2024","journal-title":"Non-Coding RNA Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"40782","DOI":"10.1007\/s11356-021-13649-4","article-title":"A functional SNP in miR-625-5p binding site of AKT2 3\u2032 UTR is associated with noise-induced hearing loss susceptibility in the Chinese population","volume":"28","author":"Miao","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"ref_31","first-page":"725","article-title":"Contribution of the Akt2 gene to type 2 diabetes in the Chinese Han population","volume":"124","author":"Sun","year":"2011","journal-title":"Chin. Med. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/db16-1329","article-title":"A Low-Frequency Inactivating Variant Enriched in the Finnish Population Is Associated with Fasting Insulin Levels and Type 2 Diabetes Risk","volume":"66","author":"Manning","year":"2017","journal-title":"Diabetes"},{"key":"ref_33","first-page":"663","article-title":"AKT1 and AKT2 mutations in lung cancer in a Japanese population","volume":"1","author":"Sasaki","year":"2008","journal-title":"Mol. Med. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13000-024-01494-1","article-title":"A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda","volume":"19","author":"Mitala","year":"2024","journal-title":"Diagn. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Shorning, B.Y., Dass, M.S., Smalley, M.J., and Pearson, H.B. (2020). The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124507"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.cdd.4400919","article-title":"Differentiation. Activation of Akt2 Inhibits anoikis and apoptosis induced by myogenic differentiation","volume":"8","author":"Fujio","year":"2001","journal-title":"Cell Death Differ."},{"key":"ref_38","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase B\u03b2 leads to up-regulation of \u03b21 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda","year":"2003","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"74820","DOI":"10.18632\/oncotarget.11204","article-title":"Akt isoform specific effects in ovarian cancer progression","volume":"7","author":"Santry","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13046-024-03207-4","article-title":"Research CC. AKT kinases as therapeutic targets","volume":"43","author":"Hassan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/bcr739","article-title":"Akt2: A role in breast cancer metastasis","volume":"6","author":"Chau","year":"2003","journal-title":"Breast Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1038\/srep12759","article-title":"Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation","volume":"5","author":"Attoub","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12931-020-01491-0","article-title":"AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma","volume":"21","author":"Liu","year":"2020","journal-title":"Respir. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20315","DOI":"10.1073\/pnas.0810715105","article-title":"Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis","volume":"105","author":"Rychahou","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cellsig.2018.01.021","article-title":"AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3\/NF-\u03baB axis","volume":"45","author":"Zheng","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jcb.10287","article-title":"Frequent activation of AKT2 kinase in human pancreatic carcinomas","volume":"87","author":"Altomare","year":"2002","journal-title":"J. Cell. Biochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:36:34Z","timestamp":1779176194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104228"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104228","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}